NCT06050902

Brief Summary

Up to two-thirds of intensive care unit patients require central venous catheterization for which ultrasound-guided placement is now recommended. In this context, the team performed a prospective randomized simulation trial on a mannequin ("reduced torso model"), to compare the standard ultrasound guidance technique with an ultrasound-guided technique assisted by a new needle-steering device. The preliminary results show a statistically significant improvement in subclavian venipuncture (shorter success time, fewer multiple skin punctures, fewer punctures of the posterior wall of the subclavian vein and needle redirection, greater comfort) and argue for a clinical trial to test the performance of this new device in situation with intensive care unit patients. The hypothesis is that the needle-steering device will result in a better success rate of subclavian venous cannulation, at first puncture, compared with the conventional ultrasound-guided technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 16, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2025

Completed
Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

September 5, 2023

Last Update Submit

February 10, 2026

Conditions

Keywords

subclavian veinneedle-steering device

Outcome Measures

Primary Outcomes (2)

  • Successful catheter insertion at first skin puncture: Control group

    The main objective is to compare the success rate of subclavian venous cannulation at first puncture between the conventional ultrasound guidance technique and ultrasound guidance assisted by a needle-steering device. Successful subclavian venous cannulation (success is defined as catheter insertion at first skin puncture). YES/NO

    Day 0

  • Successful catheter insertion at first skin puncture: Experimental group

    The main objective is to compare the success rate of subclavian venous cannulation at first puncture between the conventional ultrasound guidance technique and ultrasound guidance assisted by a needle-steering device. Successful subclavian venous cannulation (success is defined as catheter insertion at first skin puncture). YES/NO

    Day 0

Secondary Outcomes (20)

  • A. Number of skin punctures required before successful central venous catheterism: Control group

    Day 0

  • A. Number of skin punctures required before successful central venous catheterism: Experimental group

    Day 0

  • B. Complication rate. All causes, composite score: Control group

    Day 0

  • B. Complication rate. All causes, composite score: Control group

    Hour 24

  • B. Complication rate. All causes, composite score: Experimental group

    Day 0

  • +15 more secondary outcomes

Other Outcomes (16)

  • Gender

    Day 0

  • Age

    Day 0

  • Weight

    Day 0

  • +13 more other outcomes

Study Arms (2)

Standard ultrasound guidance for subclavian venipuncture

NO INTERVENTION

62 patients undergoing the usual standard ultrasound guidance technique for subclavian venipuncture

Subclavian venipuncture using the needle-steering device

EXPERIMENTAL

62 patients undergoing subclavian venipuncture using the needle-steering device

Device: Subclavian venipuncture for catheter placement using the needle-steering device

Interventions

1. Navigation software is implemented in an ultrasound machine. 2. A linear ultrasound probe (similar in appearance to a standard ultrasound probe) is used 3. Magnetization of the puncture needle after short introduction of the needle in a dedicated device. 4. Real time needle guidance on the ultrasound screen during the puncture.

Subclavian venipuncture using the needle-steering device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any resuscitation patient requiring subclavian venous catheterization.
  • Patients or representatives must have given free, informed consent and signed the consent form or patient included in an emergency situation
  • Patients must be affiliated to/or beneficiary of a health insurance scheme.
  • All patients must be adults (≥18 years of age).

You may not qualify if:

  • Moribund patients
  • Patients with severe primary or secondary hemostasis disorders (Pq \< 50 G/L or TP \< 30%, or INR \> 2).
  • Patients with a PaO2/FiO2 ratio \< 100 mmHg in mechanically ventilated patients (invasive or non-invasive ventilation).
  • Patients with a precarious or unstable respiratory status and significant risk of barotrauma
  • Patients for whom it is difficult to visualize the subclavian veins bilaterally (left and right) during ultrasound pre-screening
  • Patients with a malformation/deformity of the subclavian region (congenital or acquired: history of surgery/cervical trauma)
  • Body mass index \< 15 kg/m² ou \> 40 kg/m²
  • Local infection at the puncture site
  • Thrombosis of the subclavian or axillary vein
  • Patients participating in a category 1 defined RIPH involving subclavian central venous line placement.
  • Patients under court protection, guardianship or curatorship.
  • Pregnant, parturient or breastfeeding women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NIMES

Nîmes, 30029, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient will be blinded to his or her assignment group. The primary endpoint and secondary endpoints A, D, G, H, will be collected by an assessor independent from the operator, during the central venous catheterization procedure. This assessor will not be blinded to the technique used.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomized, patient- and evaluator-blinded, controlled superiority trial comparing standard ultrasound guidance and a new needle-steering device.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 22, 2023

Study Start

January 16, 2024

Primary Completion

December 26, 2025

Study Completion

December 26, 2025

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

The analysis of the data will be carried out by the BESPIM service of the CHU of Nîmes. Within one year after the end of the research or its interruption, a final report will be established and signed by the sponsor and the investigator. This report will be made available to the competent authority. The sponsor will transmit the results of the research in the form of a summary of the final report to the CPP (Comité de Protection des Personnes) and, if necessary, to the ANSM within one year after the end of the research.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations